KemPharm Inc
NASDAQ:KMPH
| Market Cap (Intraday) | 269.58M |
| Current PE | N/A |
| Forward PE | 27.94 |
| 2yr Forward PE | 24.36 |
| 10-Day MA | $9.27 |
| 50-Day MA | $9.69 |
| 200-Day MA | $6.71 |
KemPharm Inc Stock, NASDAQ:KMPH
1180 Celebration Boulevard, Suite 103, Celebration, Florida 34747
United States of America
Phone: +1.321.939.3416
Number of Employees: 22
Description
KemPharm, Inc. is a clinical-stage specialty pharmaceutical company, which engages in the discovery and development of proprietary prodrugs. It focuses on the treatment of serious medical conditions such as attention deficit hyperactivity disorder, pain, and other central nervous system disorders through its platform technology known as Ligand Activated Therapy. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.